All Stories

  1. Lack of Prognostic Value of T‐Wave Alternans for Implantable Cardioverter‐Defibrillator Benefit in Primary Prevention
  2. Pulsed Field Ablation of Atrial Fibrillation and Atrial Tachycardia in Adult Patients With Congenital Heart Disease
  3. Electrocardiographic risk stratification in patients with a primary prophylactic implantable cardioverter defibrillator: can future arrhythmias correlating with sudden cardiac death be predicted?
  4. Flowerpower: pulsed field ablation of ventricular tachycardia in a patient with Ebstein’s anomaly
  5. Pulmonary vein ablation in a patient with a large left common pulmonary vein joining a large right common trunk
  6. Repeating noninvasive risk stratification improves prediction of outcome in ICD patients
  7. Role of the proportion of sudden cardiac death to mortality for clinical effectiveness of primary prevention ICDs
  8. Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study
  9. Is the Tpeak-Tend interval as a measure of repolarization heterogeneity dead or just seriously wounded?
  10. To the Editor— Our doubts about the usefulness of the Tpeak-Tend interval
  11. Rationale and design of the EU-CERT-ICD prospective study: comparative effectiveness of prophylactic ICD implantation
  12. Noninvasive electrophysiology in risk assessment and screening
  13. Measurement of cardiovascular autonomic function: Where to go from here?
  14. Sex differences in outcomes of primary prevention implantable cardioverter defibrillator therapy: combined registry data from eleven European countries
  15. P1614T wave alternans in patients with an implanted cardioverter defibrillator: results of spectral and modified moving average method differ considerably
  16. T-wave loop area from a pre-implant 12-lead ECG is associated with appropriate ICD shocks
  17. ICD risk stratification studies – EU-CERT-ICD and the European perspective
  18. ICD-Therapie: Primär- und Sekundärprävention
  19. Gender Differences in Appropriate Shocks and Mortality among Patients with Primary Prophylactic Implantable Cardioverter-Defibrillators: Systematic Review and Meta-Analysis
  20. Prediction of Appropriate Shocks Using 24-Hour Holter Variables and T-Wave Alternans After First Implantable Cardioverter-Defibrillator Implantation in Patients With Ischemic or Nonischemic Cardiomyopathy
  21. Changes in Implantation Patterns and Therapy Rates of Implantable Cardioverter Defibrillators over Time in Ischemic and Dilated Cardiomyopathy Patients
  22. 153-01: Repeated assessment of non-invasive risk stratification in the EUTrigTreat study
  23. Serial assessment of left atrial deformation in patients undergoing pulmonary vein isolation: a cardiovascular magnetic resonance feasibility study
  24. Sex difference in appropriate shocks but not mortality during long-term follow-up in patients with implantable cardioverter-defibrillators
  25. Sex-dependent alterations of Ca2+cycling in human cardiac hypertrophy and heart failure
  26. Longevity of implantable cardioverter-defibrillators in a single-center population
  27. Natriuretic peptides for the detection of paroxysmal atrial fibrillation
  28. Advances in heart rate variability signal analysis: joint position statement by the e-Cardiology ESC Working Group and the European Heart Rhythm Association co-endorsed by the Asia Pacific Heart Rhythm Society
  29. A randomized study of remote monitoring and fluid monitoring for the management of patients with implanted cardiac arrhythmia devices
  30. Submuscular implantation of insertable cardiac monitors improves the reliability of detection of atrial fibrillation
  31. Sex differences in ICD benefit
  32. Rationale and design of the MONITOR-ICD study
  33. Effects of Ranolazine on Torsades de Pointes Tachycardias in a Healthy Isolated Rabbit Heart Model
  34. Measurement of Left Atrial Pressure is a Good Predictor of Freedom From Atrial Fibrillation
  35. Single-ring ablation compared with standard circumferential pulmonary vein isolation using remote magnetic catheter navigation
  36. Remote magnetic navigation for circumferential pulmonary vein ablation: single-catheter technique or additional use of a circular mapping catheter?
  37. Evaluation of machine learning methods for the long-term prediction of cardiac diseases
  38. Antiarrhythmic Drug Therapy for Maintaining Sinus Rhythm Early after Pulmonary Vein Ablation in Patients with Symptomatic Atrial Fibrillation
  39. Vorhofflimmern
  40. Ventricular Oversensing after ICD Lead Replacement: What Is the Mechanism?
  41. Ranolazine Maintained Sinus Rhythm in a Patient with Refractory Symptomatic Atrial Fibrillation
  42. Supraventricular tachycardia with ‘A-A-V’ response upon ventricular entrainment and transient 2:1 AV conduction block
  43. Double left ventricular pacing following accidental malpositioning of the right ventricular electrode during implantation of a cardiac resynchronization therapy device
  44. Atrial standstill in a patient with progressive severe heart failure
  45. Detection of left atrial thrombus during routine diagnostic work-up prior to pulmonary vein isolation for atrial fibrillation: Role of transesophageal echocardiography and multidetector computed tomography
  46. Long-Term Prognostic Value of Restitution Slope in Patients with Ischemic and Dilated Cardiomyopathies
  47. Randomized Clinical evaluatiON of wireless fluid monitoriNg and rEmote ICD managemenT using OptiVol alert-based predefined management to reduce cardiac decompensation and health care utilization: The CONNECT-OptiVol study
  48. Renal artery ablation instead of pulmonary vein ablation in a hypertensive patient with symptomatic, drug-resistant, persistent atrial fibrillation
  49. Misleading Long Post-Pacing Interval After Entrainment of Typical Atrial Flutter From the Cavotricuspid Isthmus
  50. Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype
  51. Low-energy control of electrical turbulence in the heart
  52. Remote magnetic versus manual catheter navigation for circumferential pulmonary vein ablation in patients with atrial fibrillation
  53. Kardiale Synkope
  54. Assessment of repolarization heterogeneity for prediction of mortality in cardiovascular disease: peak to the end of the T wave interval and nondipolar repolarization components
  55. Inappropriate Sensing in a Single-Chamber ICD-What is the Mechanism?
  56. T-Wave Alternans Testing in Pacemaker Patients: Comparison of Pacing Modes and Long-Term Prognostic Relevance
  57. Sternal fracture after elective electrical cardioversion of atrial fibrillation
  58. Interference of remote magnetic catheter navigation and ablation with implanted devices for pacing and defibrillation
  59. Ventricular oversensing due to manufacturer-related differences in implantable cardioverter-defibrillator signal processing and sensing lead properties
  60. Extra cardiac findings by 64-multidetector computed tomography in patients with symptomatic atrial fibrillation prior to pulmonal vein isolation
  61. Loss of capture late after right ventricular pacing lead revision: what is the mechanism?
  62. Inappropriate implantable cardioverter-defibrillator therapy during exercise: What is the mechanism?
  63. Cardiac resynchronization therapy and atrial overdrive pacing for the treatment of central sleep apnoea
  64. 64-Multidetector-row spiral CT in pulmonary embolism with emphasis on incidental findings
  65. Far-field oversensing of atrial signals: an unusual cause for very short V-V intervals and inappropriate implantable cardioverter defibrillator therapy
  66. Automatic home monitoring of implantable cardioverter defibrillators
  67. Role of Coronary Angiography Before Radiofrequency Ablation in Patients Presenting With Paroxysmal Supraventricular Tachycardia
  68. Unusual cause for an increase of the sensing integrity counter in a patient with inappropriate implantable cardioverter-defibrillator therapy
  69. Model-based inferences for clinical applications of the ECG
  70. Cardiac Arrest and Ventricular Tachycardia in Japanese-Type Apical Hypertrophic Cardiomyopathy
  71. AB13-6
  72. P3-33
  73. Arrhythmogenic right ventricular dysplasia presenting as right ventricular outflow tract tachycardia
  74. 52-j�hriger Patient mit rezidivierenden Synkopen und tempor�ren rechtspr�kordialen EKG-Ver�nderungen bei Fieber
  75. Myocardial viability evaluation using magnetocardiography in patients with coronary artery disease
  76. Tachykarde und bradykarde Rhythmusstörungen beim akuten Myokardinfarkt
  77. Antiarrhythmic therapy during cardiac arrest electrical defibrillation and antiarrhythmic drugs
  78. Antiarrhythmische Therapie beim akuten Herz-Kreislaufstillstand
  79. Predictive value of T-wave morphology variables and QT dispersion for postmyocardial infarction risk assessment
  80. Rate-dependence of QT dispersion and the QT interval: comparison of atrial pacing and exercise testing
  81. Analysis of 12-Lead T-Wave Morphology for Risk Stratification After Myocardial Infarction
  82. Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure
  83. Electrophysiological basis of QT dispersion measurements
  84. QT-Dispersion: Role in Clinical Decision Making
  85. T-Wellen-Alternans im Mikrovoltbereich als neuer Indikator einer gestörten ventrikulären Repolarisation: Pathophysiologie, Methodik, klinische Ergebnisse
  86. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era
  87. Kardialer autonomer Tonus zur Risikostratifikation nach Myokardinfarkt: Ergebnisse einer prospektiven Langzeit-Studie bei 411 konsekutiven Patienten
  88. Comparison of ECG Variables of Dispersion of Ventricular Repolarization with Direct Myocardial Repolarization Measurements in the Human Heart
  89. T Wave Alternans as a Predictor of Recurrent Ventricular Tachyarrhythmias in ICD Recipients: Prospective Comparison with Conventional Risk Markers
  90. Assessment of QT Dispersion for Prediction of Mortality or Arrhythmic Events After Myocardial Infarction : Results of a Prospective, Long-term Follow-up Study
  91. Kurzzeitanalyse der Herzfrequenzvariabilität im Zeitbereich zur Prognosebeurteilung nach Myokardinfarkt: methodologisch sinnvolle Alternative zum Langzeit-EKG?
  92. Pathophysiologische Bedeutung und prognostische Wertigkeit der QT-Dispersion im Oberflächen-EKG
  93. Differential Effects of D-Sotalol, Quinidine, and Amiodarone on Dispersion of Ventricular Repolarization in the Isolated Rabbit Heart
  94. Is Dispersion of Ventricular Repolarization Rate Dependent?
  95. Electrophysiologic Features of Torsades de Pointes:.
  96. Heart Rate Variability Used as an Arrhythmia Risk Stratifier After Myocardial Infarction
  97. T Wave Alternans During Exercise and Atrial Pacing in Humans
  98. Dispersion of Ventricular Repolarization — Myocardial and Electrocardiographic Markers
  99. Myocardial Vulnerability to T Wave Shocks: Relation to Shock Strength, Shock Coupling Interval, and Dispersion of Ventricular Repolarization
  100. Mechanism of ventricular fibrillation induction by T wave shocks in patients
  101. Lack of stability of late potentials during the first year after myocardial infarction in the thrombolytic era
  102. Effect of Sustained Load on Dispersion of Ventricular Repolarization and Conduction Time in the Isolated Intact Rabbit Heart
  103. Autonomic Modulation in Postinfarction Patients with Sustained Ventricular Tachyarrhythmias
  104. Computer Analysis of Monophasic Action Potentials: Manual Validation and Clinically Pertinent Applications
  105. Electrocardiographic indexes of dispersion of ventricular repolarization: An isolated heart validation study
  106. 947-115 Comparative Effects of D-Sotalol, Quinidine and Amiodarone on Dispersion of Ventricular Repolarization in the Isolated Intact Rabbit Heart
  107. 1055-1 A Program for Digitization of ECG Tracings on Paper and Accurate Interactive Measurement of QT Intervals and ECG Parameters of Dispersion of Ventricular Repolarization
  108. Open infarct artery, late potentials, and other prognostic factors in patients after acute myocardial infarction in the thrombolytic era. A prospective trial
  109. Changes in Autonomic Tone Following Thrombolytic Therapy for Acute Myocardial Infarction:.
  110. Bedeutung des autonomen Nervensystems bei paroxysmalem Vorhofflimmern
  111. Bedside markers of coronary reperfusion
  112. Effect of sotalol on heart rate variability assessed by Holter monitoring in patients with ventricular arrhythmias
  113. Relation of diurnal variation of ventricular repolarization to ventricular ectopic activity and modification by sotalol
  114. Usefulness of ckmb and troponin t determinations in patients with acute myocardial infarction complicated by ventricular fibrillation
  115. Efficacy and safety of sotalol in patients with complex ventricular arrhythmias
  116. Efficacy of Intravenously Administered Amiodarone for Short-Term Control of Serious Arrhythmias
  117. ST segment analysis for assessment of coronary artery patency: comparison of surface ECG and Holter recordings
  118. Intraindividual Reproducibility of Heart Rate Variability
  119. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias
  120. Arrhythmias during the acute phase of reperfusion therapy for acute myocardial infarction: Effects of β-adrenergic blockade
  121. Short- and long-term antiarrhythmic and hemodynamic effects of d,l-sotalol in patients with symptomatic ventricular arrhythmias
  122. Efficacy of Intravenously Administered Amiodarone for Short-Term Control of Serious Arrhythmias
  123. Assessment of coronary artery patency after thrombolytic therapy: Accurate prediction utilizing the combined analysis of three noninvasive markers
  124. Combined analysis of three noninvasive harkers for better prediction of reperfusion after thrombolytic therapy for acute myocardial infarction
  125. Neue Aspekte zur Therapie mit Klasse-III-Antiarrhythmika
  126. Comparison of twice daily with thrice daily administered encainide for benign or potentially lethal ventricular arrhythmias
  127. Morphological Assessment of T Wave Patterns